|
In addition to the company name change, the visual identity of the company will be gradually renewed during this spring. FinnMedi Oy is an international life sciences service company which develops wellness business and product seeds into products, services and innovations. The company’s range of services includes services related to clinical research and business development in the life sciences sector. The service range will also be developed and further enhanced to answer future needs.
The change of name doesn’t apply to the buildings and activities in the Finn-Medi campus area. The name of the area will continue to be Finn-Medi (please note the spelling) and the buildings will continue to be named by number: Finn-Medi 1, Finn-Medi 2, etc. Changes founded on strategic development The change of name is the result of strategic development implemented due to ongoing changes in the market. Changes which have been taking place for some time have also brought clear pressure to adapt the company’s marketing and communications. “The national and international operating environment is changing, and it has already partly changed in a way that has a significant impact on the operations of mediating organizations. Public funders, for example, have adjusted their funding principles towards customer funding and purchased services. This change has had an effect both on development services for companies and on university activities,” says CEO of FinnMedi Oy Matti Eskola. In addition, the position of mediator organizations as regional players has not been clarified. National development programmes emphasize national and international activity, and the same is reflected in research institutions. “This in turn has contributed to the company’s need to assess and develop its operations through a new perspective,” Eskola explains. In future, FinnMedi Oy will focus more clearly on international company projects. “FinnMedi Oy’s future is that of a partner for international companies and leading-edge research projects. We have and will continue to strongly invest in forwarding this objective. Despite hard international competition, FinnMedi Oy has every chance of success,” Eskola says. “In our services, we are now focusing on the content areas in which the company and its partners already possess natural international strengths and expertise, such as biomaterials, celiac disease research and medical technology.” Further information:
Matti Eskola, CEO, FinnMedi Oy, tel. +358 40 557 5355, matti.eskola(at)finnmedi.com Suvi Keituri, Communications Manager, FinnMedi Oy, tel. +358 40 350 6925, suvi.keituri(at)finnmedi.com The FinnMedi website is now at www.finnmedi.com and staff email addresses are in the format firstname.lastname(at)finnmedi.com.
|
